ConductScience.org, home

Paper37628906

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.

Zhang Y and 5 others. Int J Mol Sci, 2023. Cited by 77 papers, by iCite.

Cite this record

ConductScience Library. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. Papers, record 37628906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37628906

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
11.9
iCite
Revised in PubMed
2023-08-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYingqian
2Wu CChenyuan
3Zhang NNana
4Fan RRui
5Ye YYanghttps://orcid.org/0000-0001-5279-8104
6Xu JJunhttps://orcid.org/0000-0002-8898-3747

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Pyrazoles
Cell Line
Structure-Activity Relationship
Tubulin

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22207027NFSCPubMed
LQ22B020003Fund Committee of Zhejiang ProvincePubMed
2021QDL041Hangzhou Normal UniversityPubMed

Source PubMed

Download CSV of grants

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129031622Haspin: a promising target for the design of inhibitors as potent anticancer drugs.Drug Discov Today2018https://conductscience.org/library/papers/29031622PubMed
230849534The relation between PI3K/AKT signalling pathway and cancer.Gene2019https://conductscience.org/library/papers/30849534PubMed
329567429Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.Bioorg Chem2018https://conductscience.org/library/papers/29567429PubMed
435741451Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro.Biology (Basel)2022https://conductscience.org/library/papers/35741451PubMed
527653758Apixaban: A Review in Venous Thromboembolism.Drugs2016https://conductscience.org/library/papers/27653758PubMed
618852116Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling.Mol Cancer Ther2008https://conductscience.org/library/papers/18852116PubMed
729268127Design, synthesis and biological evaluation of 1, 4-dihydro indeno[1,2-c] pyrazole linked oxindole analogues as potential anticancer agents targeting tubulin and inducing p53 dependent apoptosis.Eur J Med Chem2018https://conductscience.org/library/papers/29268127PubMed
830149323Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.Eur J Med Chem2018https://conductscience.org/library/papers/30149323PubMed
932039146Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors.Front Chem2019https://conductscience.org/library/papers/32039146PubMed
1034818572Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative.Eur J Pharm Sci2022https://conductscience.org/library/papers/34818572PubMed
1130006168Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.Eur J Med Chem2018https://conductscience.org/library/papers/30006168PubMed
1230606674Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors.Bioorg Med Chem2019https://conductscience.org/library/papers/30606674PubMed
1330332801Anticancer and Anti-Inflammatory Activities of Some New Pyrazolo[3,4-b]pyrazines.Molecules2018https://conductscience.org/library/papers/30332801PubMed
1432559576Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase.Bioorg Chem2020https://conductscience.org/library/papers/32559576PubMed
1530221233Copper-Catalyzed Syntheses of Pyrene-Pyrazole Pharmacophores and Structure Activity Studies for Tubulin Polymerization.ACS Omega2018https://conductscience.org/library/papers/30221233PubMed
1630981111Targeting hepatocellular carcinoma: Synthesis of new pyrazole-based derivatives, biological evaluation, DNA binding, and molecular modeling studies.Bioorg Chem2019https://conductscience.org/library/papers/30981111PubMed
1729433928Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.Bioorg Med Chem Lett2018https://conductscience.org/library/papers/29433928PubMed
1829232583Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.Eur J Med Chem2018https://conductscience.org/library/papers/29232583PubMed
1936411633Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action.Biomed Pharmacother2022https://conductscience.org/library/papers/36411633PubMed
2036067564Mechanism and inhibition of BRAF kinase.Curr Opin Chem Biol2022https://conductscience.org/library/papers/36067564PubMed

See all 110 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
42653326Dual Anticancer and Antibacterial Applications of Active Particle Aggregates Containing Metal Phthalocyanines in Dark.Int J Mol Sci2026https://conductscience.org/library/papers/42653326PubMed
42515760Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515760PubMed
42357430Heteroaromatic Pyrazole-Based Carbohydrazones: Structure-Dependent Redox Activity, DNA-Associated Spectroscopic Behavior, and Multifunctional Biological Properties.Molecules2026https://conductscience.org/library/papers/42357430PubMed
42225755Targeting colorectal cancer with pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides: comprehensive in vitro evaluation.Sci Rep2026https://conductscience.org/library/papers/42225755PubMed
42147720Novel N-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance.Cancer Drug Resist2026https://conductscience.org/library/papers/42147720PubMed
42130847Synthesis and antimitotic activity of 2-phenyl-6-pyridinyl-2H-pyrazolo[4,3-c]pyridines.RSC Adv2026https://conductscience.org/library/papers/42130847PubMed
42074046The Pyrazole Scaffold in Anticancer Drug Discovery: A Review of Synthetic Approaches, Structure-Activity Relationships, and Target-Based Mechanism of Action.Int J Mol Sci2026https://conductscience.org/library/papers/42074046PubMed
41930163Discovery of Two Novel Pyrazole Derivatives as Anticancer Agents Targeting Tubulin Polymerization and MAPK Signaling Pathways.Oncol Res2026https://conductscience.org/library/papers/41930163PubMed
41901229Synthesis and Development of 3-((2,4-Difluorophenyl)Amino)Propanoic Acid Derivatives as an Antiproliferative Medicinal Chemistry Scaffold Targeting Growth Factor Receptors.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901229PubMed
41841329Multi-targeted pyrazole scaffolds: synthesis, mechanistic insights, and therapeutic potential in anticancer, antioxidant, and anti-inflammatory applications.Libyan J Med2026https://conductscience.org/library/papers/41841329PubMed
41754878Azole-Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41754878PubMed
41599605Synthesis, Characterization, Antimicrobial and Anticancer Evaluation of Novel Heterocyclic Diazene Compounds Derived from 8-Quinolinol.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41599605PubMed
41575480Recent advances in carbonyl infused bis-pyrazoles: relevance, synthetic developments and biological significance.Mol Divers2026https://conductscience.org/library/papers/41575480PubMed
41548057Molecular Hybridization Strategy for Developing Lipid-Lowering Compounds: Design and Synthesis of Vanillin-Based Fibrate Derivatives.Chem Biodivers2026https://conductscience.org/library/papers/41548057PubMed
41226375Switching N-Alkylation Regioselectivity of Trifluoromethylated Pyrazoles Guided by Functional Group Tuning.Int J Mol Sci2025https://conductscience.org/library/papers/41226375PubMed
41053951Preparation of Hierarchically Structured Perlite NPs/Metformin-Co (II) System to Catalyze the Green Synthesis of Pyrazolopyranopyrimidines.ChemistryOpen2025https://conductscience.org/library/papers/41053951PubMed
40985933Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression-A Comprehensive Review.Phytother Res2025https://conductscience.org/library/papers/40985933PubMed
40807478Synthesis and Biological Evaluation of β-Phenylalanine Derivatives Containing Sulphonamide and Azole Moieties as Antiproliferative Candidates in Lung Cancer Models.Molecules2025https://conductscience.org/library/papers/40807478PubMed
40649394Synthesis of Novel Tetra-Substituted Pyrazole Derivatives Using Microwave Irradiation and Their Anti-Leukemic Activity Against Jurkat Cells.Molecules2025https://conductscience.org/library/papers/40649394PubMed
40511659A Review of Research from 2012 to 2024 on Pyrazole-based Anticancer Agents with SAR Study.Curr Top Med Chem2026https://conductscience.org/library/papers/40511659PubMed

See all 42 cited byDownload CSV of cited by

Genes57

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACLY47PubTator's text mininghttps://conductscience.org/library/genes/47NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
APAF1317PubTator's text mininghttps://conductscience.org/library/genes/317NCBI Gene
ASNS440PubTator's text mininghttps://conductscience.org/library/genes/440NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CCNA18900PubTator's text mininghttps://conductscience.org/library/genes/8900NCBI Gene
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
CDC25C995PubTator's text mininghttps://conductscience.org/library/genes/995NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDK91025PubTator's text mininghttps://conductscience.org/library/genes/1025NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CREB11385PubTator's text mininghttps://conductscience.org/library/genes/1385NCBI Gene
CYCS54205PubTator's text mininghttps://conductscience.org/library/genes/54205NCBI Gene

See all 57 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37628906

GET https://conductscience.org/api/papers/v1/37628906/references?page=2